{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:31:04Z","timestamp":1781587864537,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6549,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1093\/annonc\/mdf036","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T19:00:36Z","timestamp":1027710036000},"page":"218-221","source":"Crossref","is-referenced-by-count":36,"title":["Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect"],"prefix":"10.1016","volume":"13","author":[{"given":"B.","family":"Esmaeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Esteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Booser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Delpassand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf036_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1200\/JCO.1996.14.1.58","article-title":"Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer","volume":"14","author":"Hudis","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf036_bb0015","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1200\/JCO.1995.13.12.2886","article-title":"Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer","volume":"13","author":"Valero","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf036_bb0020","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.1995.13.10.2643","volume":"13","author":"Cortes","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf036_bb0025","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.1998.16.6.2164","article-title":"Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer","volume":"16","author":"Hainsworth","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf036_bb0030","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1200\/JCO.2000.18.6.1212","article-title":"Docetaxel administered on a weekly basis for metastatic breast cancer","volume":"18","author":"Burstein","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3 Suppl 9","key":"10.1093\/annonc\/mdf036_bb0035","first-page":"32","article-title":"Recent progress in the clinical development of docetaxel (taxotere)","volume":"26","author":"Hortobagyi","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdf036_bb0040","series-title":"The Lacrimal System","first-page":"47","author":"Hurwitz","year":"1996"},{"key":"10.1093\/annonc\/mdf036_bb0045","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0161-6420(00)00640-0","article-title":"Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect","volume":"108","author":"Esmaeli","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1093\/annonc\/mdf036_bb0050","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1200\/JCO.2001.19.15.3500","article-title":"Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl cancer research network phase II trial","volume":"19","author":"Hainsworth","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf036_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1634\/theoncologist.6-suppl_3-26","article-title":"Weekly docetaxel in breast cancer: applying clinical data to patient therapy","volume":"6","author":"Baselga","year":"2001","journal-title":"Oncologist"},{"issue":"5 Suppl 12","key":"10.1093\/annonc\/mdf036_bb0060","first-page":"32","article-title":"Is there a place for \u201cdose-dense\u201d weekly schedules of the taxoids?","volume":"25","author":"Loffler","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdf036_bb0065","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.1994.12.7.1458","article-title":"Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis","volume":"12","author":"Tomiak","year":"1994","journal-title":"JClin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419628048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419628048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/2\/218\/19479702\/218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:29:05Z","timestamp":1582165745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419628048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0923753419628048"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf036","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}